<DOC>
	<DOCNO>NCT00388973</DOCNO>
	<brief_summary>The primary purpose study evaluate whether treatment ( SEROQUEL SR ) quetiapine fumarate sustain release ( SR ) 9 week compare placebo improve depressive symptom elderly patient major depressive disorder . PLEASE NOTE : Seroquel SR Seroquel XR refer formulation . The SR designation change XR consultation FDA .</brief_summary>
	<brief_title>Efficacy Safety Study Seroquel SR Treatment Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Male female patient , 66 year old , document clinical diagnosis MDD . The presence dementia mental disorder MDD within 6 month enrolment , Uncontrolled hypertension , substance alcohol abuse A current diagnosis cancer current past diagnosis stroke</criteria>
	<gender>All</gender>
	<minimum_age>66 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
</DOC>